Why Is Neutrogena Facing Backlash Over Hayden Panettiere? What Happened Between the Actress and the Brand
Neutrogena has responded to growing criticism surrounding its former ambassador Hayden Panettiere, acknowledging that the actress felt unsupported during a difficult period after publicly discussing her experience with postpartum depression.
The skincare company said Thursday that it was “deeply saddened” by Panettiere’s death and announced plans for a “significant investment” with a community healthcare partner to improve women’s access to postpartum depression care and related resources.
The statement comes after renewed attention to Panettiere’s account of her relationship with the brand, which she discussed again in her 2026 memoir, This Is Me: A Reckoning.
Neutrogena Acknowledges Panettiere’s Experience
Panettiere was part of the Neutrogena brand for more than a decade, making the relationship one of the longer celebrity partnerships in the company’s history.
In its statement, Neutrogena said it was proud to have worked with her but also recognized that its former ambassador felt unsupported during a particularly difficult period.
The company added that this was not what Neutrogena stands for or who it wants to be.
The response represents the brand’s first major public acknowledgment of the criticism surrounding Panettiere’s account.
The Disclosure That Changed the Story
Panettiere publicly discussed her struggle with postpartum depression after giving birth to her daughter in 2014.
During a 2015 television appearance, she spoke openly about the condition and the difficulties she was experiencing. Her disclosure helped bring greater public attention to postpartum depression, particularly among women who may otherwise hesitate to discuss their mental health.
Panettiere later said the disclosure affected her relationship with Neutrogena.
Her account became more widely discussed again after the publication of her memoir in May 2026.
A Partnership That Lasted About a Decade
Panettiere’s connection with Neutrogena began when she was a teenager.
Over the following years, she became one of the recognizable faces associated with the skincare brand and appeared in its advertising campaigns while continuing to build her acting career.
The length of the relationship is significant because the current dispute concerns a longstanding professional association rather than a brief promotional arrangement.
Why Postpartum Depression Is Central to the Debate
Postpartum depression is a serious mental-health condition that can develop after childbirth.
Unlike the temporary emotional changes often experienced after having a baby, postpartum depression can persist and affect a person’s ability to function, care for themselves or connect with their child.
Treatment can involve psychotherapy, medication or other professional support.
Panettiere’s openness about her own experience made postpartum depression part of her public story years before the current controversy involving Neutrogena.
What Neutrogena Plans to Do
The company has paired its statement with a commitment to women’s health.
Neutrogena said it would make a significant investment with a community healthcare partner focused on improving access to postpartum depression resources and care.
The company has not disclosed the amount of the investment or named the partner.
That leaves the practical impact of the initiative to be determined as further details emerge.
Why the Controversy Has Resurfaced
The criticism has gained renewed attention because several parts of Panettiere’s story have converged in a short period.
Her memoir revisited difficult experiences from her life and career, including motherhood, addiction, recovery and mental health. Her death at 36 then brought fresh public scrutiny to accounts she had previously shared.
The result has been renewed examination of how the actress’s former corporate partners responded when she spoke publicly about her health.
Panettiere’s Wider Career
The controversy has also renewed interest in the career that made Panettiere a recognizable figure long before her relationship with Neutrogena became part of the discussion.
She began acting as a child and became widely known for “Heroes” before taking a leading role in “Nashville.” She also appeared as Kirby Reed in the Scream franchise.
Her public profile later extended beyond acting as she spoke more openly about addiction, recovery and motherhood.
What the Latest Development Does Not Establish
The renewed discussion around Neutrogena should not be confused with the circumstances of Panettiere’s death.
There is no established evidence in the information currently available that connects her death to postpartum depression or to her former relationship with Neutrogena.
The current controversy concerns her account of how the brand relationship changed after she spoke publicly about her mental health and the company’s response to that history.
The Bottom Line
Neutrogena’s response has shifted the focus from an old celebrity-brand partnership to a broader conversation about mental health, corporate responsibility and access to postpartum care.
The company has acknowledged that Panettiere felt unsupported and says it will invest in resources for women experiencing postpartum depression.
What remains to be seen is how that commitment will be implemented—and whether it will change the public reaction to a controversy that has resurfaced years after Panettiere first spoke about her experience.
